Indolent Lymphoma Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Indolent Lymphoma Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Indolent Lymphoma Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Indolent Lymphoma Treatment Overall Market Size
2.1 Global Indolent Lymphoma Treatment Market Size: 2023 VS 2030
2.2 Global Indolent Lymphoma Treatment Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Indolent Lymphoma Treatment Players in Global Market
3.2 Top Global Indolent Lymphoma Treatment Companies Ranked by Revenue
3.3 Global Indolent Lymphoma Treatment Revenue by Companies
3.4 Top 3 and Top 5 Indolent Lymphoma Treatment Companies in Global Market, by Revenue in 2023
3.5 Global Companies Indolent Lymphoma Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Indolent Lymphoma Treatment Players in Global Market
3.6.1 List of Global Tier 1 Indolent Lymphoma Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Indolent Lymphoma Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Indolent Lymphoma Treatment Market Size Markets, 2023 & 2030
4.1.2 BI-836826
4.1.3 ALT-803
4.1.4 BMS-986016
4.1.5 CC-122
4.1.6 Others
4.2 By Type - Global Indolent Lymphoma Treatment Revenue & Forecasts
4.2.1 By Type - Global Indolent Lymphoma Treatment Revenue, 2019-2024
4.2.2 By Type - Global Indolent Lymphoma Treatment Revenue, 2025-2030
4.2.3 By Type - Global Indolent Lymphoma Treatment Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Indolent Lymphoma Treatment Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Indolent Lymphoma Treatment Revenue & Forecasts
5.2.1 By Application - Global Indolent Lymphoma Treatment Revenue, 2019-2024
5.2.2 By Application - Global Indolent Lymphoma Treatment Revenue, 2025-2030
5.2.3 By Application - Global Indolent Lymphoma Treatment Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Indolent Lymphoma Treatment Market Size, 2023 & 2030
6.2 By Region - Global Indolent Lymphoma Treatment Revenue & Forecasts
6.2.1 By Region - Global Indolent Lymphoma Treatment Revenue, 2019-2024
6.2.2 By Region - Global Indolent Lymphoma Treatment Revenue, 2025-2030
6.2.3 By Region - Global Indolent Lymphoma Treatment Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Indolent Lymphoma Treatment Revenue, 2019-2030
6.3.2 US Indolent Lymphoma Treatment Market Size, 2019-2030
6.3.3 Canada Indolent Lymphoma Treatment Market Size, 2019-2030
6.3.4 Mexico Indolent Lymphoma Treatment Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Indolent Lymphoma Treatment Revenue, 2019-2030
6.4.2 Germany Indolent Lymphoma Treatment Market Size, 2019-2030
6.4.3 France Indolent Lymphoma Treatment Market Size, 2019-2030
6.4.4 U.K. Indolent Lymphoma Treatment Market Size, 2019-2030
6.4.5 Italy Indolent Lymphoma Treatment Market Size, 2019-2030
6.4.6 Russia Indolent Lymphoma Treatment Market Size, 2019-2030
6.4.7 Nordic Countries Indolent Lymphoma Treatment Market Size, 2019-2030
6.4.8 Benelux Indolent Lymphoma Treatment Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Indolent Lymphoma Treatment Revenue, 2019-2030
6.5.2 China Indolent Lymphoma Treatment Market Size, 2019-2030
6.5.3 Japan Indolent Lymphoma Treatment Market Size, 2019-2030
6.5.4 South Korea Indolent Lymphoma Treatment Market Size, 2019-2030
6.5.5 Southeast Asia Indolent Lymphoma Treatment Market Size, 2019-2030
6.5.6 India Indolent Lymphoma Treatment Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Indolent Lymphoma Treatment Revenue, 2019-2030
6.6.2 Brazil Indolent Lymphoma Treatment Market Size, 2019-2030
6.6.3 Argentina Indolent Lymphoma Treatment Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Indolent Lymphoma Treatment Revenue, 2019-2030
6.7.2 Turkey Indolent Lymphoma Treatment Market Size, 2019-2030
6.7.3 Israel Indolent Lymphoma Treatment Market Size, 2019-2030
6.7.4 Saudi Arabia Indolent Lymphoma Treatment Market Size, 2019-2030
6.7.5 UAE Indolent Lymphoma Treatment Market Size, 2019-2030
7 Indolent Lymphoma Treatment Companies Profiles
7.1 Altor BioScience Corporation
7.1.1 Altor BioScience Corporation Company Summary
7.1.2 Altor BioScience Corporation Business Overview
7.1.3 Altor BioScience Corporation Indolent Lymphoma Treatment Major Product Offerings
7.1.4 Altor BioScience Corporation Indolent Lymphoma Treatment Revenue in Global Market (2019-2024)
7.1.5 Altor BioScience Corporation Key News & Latest Developments
7.2 Amgen Inc.
7.2.1 Amgen Inc. Company Summary
7.2.2 Amgen Inc. Business Overview
7.2.3 Amgen Inc. Indolent Lymphoma Treatment Major Product Offerings
7.2.4 Amgen Inc. Indolent Lymphoma Treatment Revenue in Global Market (2019-2024)
7.2.5 Amgen Inc. Key News & Latest Developments
7.3 Astellas Pharma Inc.
7.3.1 Astellas Pharma Inc. Company Summary
7.3.2 Astellas Pharma Inc. Business Overview
7.3.3 Astellas Pharma Inc. Indolent Lymphoma Treatment Major Product Offerings
7.3.4 Astellas Pharma Inc. Indolent Lymphoma Treatment Revenue in Global Market (2019-2024)
7.3.5 Astellas Pharma Inc. Key News & Latest Developments
7.4 Bayer AG
7.4.1 Bayer AG Company Summary
7.4.2 Bayer AG Business Overview
7.4.3 Bayer AG Indolent Lymphoma Treatment Major Product Offerings
7.4.4 Bayer AG Indolent Lymphoma Treatment Revenue in Global Market (2019-2024)
7.4.5 Bayer AG Key News & Latest Developments
7.5 Boehringer Ingelheim GmbH
7.5.1 Boehringer Ingelheim GmbH Company Summary
7.5.2 Boehringer Ingelheim GmbH Business Overview
7.5.3 Boehringer Ingelheim GmbH Indolent Lymphoma Treatment Major Product Offerings
7.5.4 Boehringer Ingelheim GmbH Indolent Lymphoma Treatment Revenue in Global Market (2019-2024)
7.5.5 Boehringer Ingelheim GmbH Key News & Latest Developments
7.6 Bristol-Myers Squibb Company
7.6.1 Bristol-Myers Squibb Company Company Summary
7.6.2 Bristol-Myers Squibb Company Business Overview
7.6.3 Bristol-Myers Squibb Company Indolent Lymphoma Treatment Major Product Offerings
7.6.4 Bristol-Myers Squibb Company Indolent Lymphoma Treatment Revenue in Global Market (2019-2024)
7.6.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.7 Celgene Corporation
7.7.1 Celgene Corporation Company Summary
7.7.2 Celgene Corporation Business Overview
7.7.3 Celgene Corporation Indolent Lymphoma Treatment Major Product Offerings
7.7.4 Celgene Corporation Indolent Lymphoma Treatment Revenue in Global Market (2019-2024)
7.7.5 Celgene Corporation Key News & Latest Developments
7.8 Eli Lilly and Company
7.8.1 Eli Lilly and Company Company Summary
7.8.2 Eli Lilly and Company Business Overview
7.8.3 Eli Lilly and Company Indolent Lymphoma Treatment Major Product Offerings
7.8.4 Eli Lilly and Company Indolent Lymphoma Treatment Revenue in Global Market (2019-2024)
7.8.5 Eli Lilly and Company Key News & Latest Developments
7.9 F. Hoffmann-La Roche Ltd.
7.9.1 F. Hoffmann-La Roche Ltd. Company Summary
7.9.2 F. Hoffmann-La Roche Ltd. Business Overview
7.9.3 F. Hoffmann-La Roche Ltd. Indolent Lymphoma Treatment Major Product Offerings
7.9.4 F. Hoffmann-La Roche Ltd. Indolent Lymphoma Treatment Revenue in Global Market (2019-2024)
7.9.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.10 Gilead Sciences, Inc.
7.10.1 Gilead Sciences, Inc. Company Summary
7.10.2 Gilead Sciences, Inc. Business Overview
7.10.3 Gilead Sciences, Inc. Indolent Lymphoma Treatment Major Product Offerings
7.10.4 Gilead Sciences, Inc. Indolent Lymphoma Treatment Revenue in Global Market (2019-2024)
7.10.5 Gilead Sciences, Inc. Key News & Latest Developments
7.11 Incyte Corporation
7.11.1 Incyte Corporation Company Summary
7.11.2 Incyte Corporation Business Overview
7.11.3 Incyte Corporation Indolent Lymphoma Treatment Major Product Offerings
7.11.4 Incyte Corporation Indolent Lymphoma Treatment Revenue in Global Market (2019-2024)
7.11.5 Incyte Corporation Key News & Latest Developments
7.12 Infinity Pharmaceuticals, Inc.
7.12.1 Infinity Pharmaceuticals, Inc. Company Summary
7.12.2 Infinity Pharmaceuticals, Inc. Business Overview
7.12.3 Infinity Pharmaceuticals, Inc. Indolent Lymphoma Treatment Major Product Offerings
7.12.4 Infinity Pharmaceuticals, Inc. Indolent Lymphoma Treatment Revenue in Global Market (2019-2024)
7.12.5 Infinity Pharmaceuticals, Inc. Key News & Latest Developments
7.13 Juno Therapeutics Inc.
7.13.1 Juno Therapeutics Inc. Company Summary
7.13.2 Juno Therapeutics Inc. Business Overview
7.13.3 Juno Therapeutics Inc. Indolent Lymphoma Treatment Major Product Offerings
7.13.4 Juno Therapeutics Inc. Indolent Lymphoma Treatment Revenue in Global Market (2019-2024)
7.13.5 Juno Therapeutics Inc. Key News & Latest Developments
7.14 MedImmune, LLC
7.14.1 MedImmune, LLC Company Summary
7.14.2 MedImmune, LLC Business Overview
7.14.3 MedImmune, LLC Indolent Lymphoma Treatment Major Product Offerings
7.14.4 MedImmune, LLC Indolent Lymphoma Treatment Revenue in Global Market (2019-2024)
7.14.5 MedImmune, LLC Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Indolent Lymphoma Treatment Market Opportunities & Trends in Global Market
Table 2. Indolent Lymphoma Treatment Market Drivers in Global Market
Table 3. Indolent Lymphoma Treatment Market Restraints in Global Market
Table 4. Key Players of Indolent Lymphoma Treatment in Global Market
Table 5. Top Indolent Lymphoma Treatment Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Indolent Lymphoma Treatment Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Indolent Lymphoma Treatment Revenue Share by Companies, 2019-2024
Table 8. Global Companies Indolent Lymphoma Treatment Product Type
Table 9. List of Global Tier 1 Indolent Lymphoma Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Indolent Lymphoma Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Indolent Lymphoma Treatment Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Indolent Lymphoma Treatment Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Indolent Lymphoma Treatment Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Indolent Lymphoma Treatment Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Indolent Lymphoma Treatment Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Indolent Lymphoma Treatment Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Indolent Lymphoma Treatment Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Indolent Lymphoma Treatment Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Indolent Lymphoma Treatment Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Indolent Lymphoma Treatment Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Indolent Lymphoma Treatment Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Indolent Lymphoma Treatment Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Indolent Lymphoma Treatment Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Indolent Lymphoma Treatment Revenue, (US$, Mn), 2025-2030
Table 30. Altor BioScience Corporation Company Summary
Table 31. Altor BioScience Corporation Indolent Lymphoma Treatment Product Offerings
Table 32. Altor BioScience Corporation Indolent Lymphoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 33. Altor BioScience Corporation Key News & Latest Developments
Table 34. Amgen Inc. Company Summary
Table 35. Amgen Inc. Indolent Lymphoma Treatment Product Offerings
Table 36. Amgen Inc. Indolent Lymphoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 37. Amgen Inc. Key News & Latest Developments
Table 38. Astellas Pharma Inc. Company Summary
Table 39. Astellas Pharma Inc. Indolent Lymphoma Treatment Product Offerings
Table 40. Astellas Pharma Inc. Indolent Lymphoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 41. Astellas Pharma Inc. Key News & Latest Developments
Table 42. Bayer AG Company Summary
Table 43. Bayer AG Indolent Lymphoma Treatment Product Offerings
Table 44. Bayer AG Indolent Lymphoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 45. Bayer AG Key News & Latest Developments
Table 46. Boehringer Ingelheim GmbH Company Summary
Table 47. Boehringer Ingelheim GmbH Indolent Lymphoma Treatment Product Offerings
Table 48. Boehringer Ingelheim GmbH Indolent Lymphoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 49. Boehringer Ingelheim GmbH Key News & Latest Developments
Table 50. Bristol-Myers Squibb Company Company Summary
Table 51. Bristol-Myers Squibb Company Indolent Lymphoma Treatment Product Offerings
Table 52. Bristol-Myers Squibb Company Indolent Lymphoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 53. Bristol-Myers Squibb Company Key News & Latest Developments
Table 54. Celgene Corporation Company Summary
Table 55. Celgene Corporation Indolent Lymphoma Treatment Product Offerings
Table 56. Celgene Corporation Indolent Lymphoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 57. Celgene Corporation Key News & Latest Developments
Table 58. Eli Lilly and Company Company Summary
Table 59. Eli Lilly and Company Indolent Lymphoma Treatment Product Offerings
Table 60. Eli Lilly and Company Indolent Lymphoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 61. Eli Lilly and Company Key News & Latest Developments
Table 62. F. Hoffmann-La Roche Ltd. Company Summary
Table 63. F. Hoffmann-La Roche Ltd. Indolent Lymphoma Treatment Product Offerings
Table 64. F. Hoffmann-La Roche Ltd. Indolent Lymphoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 65. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 66. Gilead Sciences, Inc. Company Summary
Table 67. Gilead Sciences, Inc. Indolent Lymphoma Treatment Product Offerings
Table 68. Gilead Sciences, Inc. Indolent Lymphoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 69. Gilead Sciences, Inc. Key News & Latest Developments
Table 70. Incyte Corporation Company Summary
Table 71. Incyte Corporation Indolent Lymphoma Treatment Product Offerings
Table 72. Incyte Corporation Indolent Lymphoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 73. Incyte Corporation Key News & Latest Developments
Table 74. Infinity Pharmaceuticals, Inc. Company Summary
Table 75. Infinity Pharmaceuticals, Inc. Indolent Lymphoma Treatment Product Offerings
Table 76. Infinity Pharmaceuticals, Inc. Indolent Lymphoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 77. Infinity Pharmaceuticals, Inc. Key News & Latest Developments
Table 78. Juno Therapeutics Inc. Company Summary
Table 79. Juno Therapeutics Inc. Indolent Lymphoma Treatment Product Offerings
Table 80. Juno Therapeutics Inc. Indolent Lymphoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 81. Juno Therapeutics Inc. Key News & Latest Developments
Table 82. MedImmune, LLC Company Summary
Table 83. MedImmune, LLC Indolent Lymphoma Treatment Product Offerings
Table 84. MedImmune, LLC Indolent Lymphoma Treatment Revenue (US$, Mn) & (2019-2024)
Table 85. MedImmune, LLC Key News & Latest Developments
List of Figures
Figure 1. Indolent Lymphoma Treatment Segment by Type in 2023
Figure 2. Indolent Lymphoma Treatment Segment by Application in 2023
Figure 3. Global Indolent Lymphoma Treatment Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Indolent Lymphoma Treatment Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Indolent Lymphoma Treatment Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Indolent Lymphoma Treatment Revenue in 2023
Figure 8. By Type - Global Indolent Lymphoma Treatment Revenue Market Share, 2019-2030
Figure 9. By Application - Global Indolent Lymphoma Treatment Revenue Market Share, 2019-2030
Figure 10. By Type - Global Indolent Lymphoma Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Indolent Lymphoma Treatment Revenue Market Share, 2019-2030
Figure 12. By Application - Global Indolent Lymphoma Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Indolent Lymphoma Treatment Revenue Market Share, 2019-2030
Figure 14. By Region - Global Indolent Lymphoma Treatment Revenue Market Share, 2019-2030
Figure 15. By Country - North America Indolent Lymphoma Treatment Revenue Market Share, 2019-2030
Figure 16. US Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Indolent Lymphoma Treatment Revenue Market Share, 2019-2030
Figure 20. Germany Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 21. France Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Indolent Lymphoma Treatment Revenue Market Share, 2019-2030
Figure 28. China Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 32. India Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Indolent Lymphoma Treatment Revenue Market Share, 2019-2030
Figure 34. Brazil Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Indolent Lymphoma Treatment Revenue Market Share, 2019-2030
Figure 37. Turkey Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Indolent Lymphoma Treatment Revenue, (US$, Mn), 2019-2030
Figure 41. Altor BioScience Corporation Indolent Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Amgen Inc. Indolent Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Astellas Pharma Inc. Indolent Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Bayer AG Indolent Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Boehringer Ingelheim GmbH Indolent Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Bristol-Myers Squibb Company Indolent Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Celgene Corporation Indolent Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Eli Lilly and Company Indolent Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. F. Hoffmann-La Roche Ltd. Indolent Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Gilead Sciences, Inc. Indolent Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Incyte Corporation Indolent Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Infinity Pharmaceuticals, Inc. Indolent Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Juno Therapeutics Inc. Indolent Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. MedImmune, LLC Indolent Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Industry Market Size
